Author

Y. Ramos

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Biochemistry· 2 Bioengineering· 1 Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 7 Approach:experimental assay· 6 Organism:human· 4 Research Focus:host-pathogen & immune response· 3 Research Focus:protein folding & dynamics· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

L. J. Gonzalez· 6 shared V. Besada· 5 shared J. R. Wisniewski· 4 shared Y. Perera· 4 shared A. C. Ramon· 3 shared A. Rodriguez-Ulloa· 3 shared G. V. Perez· 3 shared M. Rosales· 3 shared

Activity by Year

2020-2022 · peak 6/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

6 shared papersCancer Biology

L. J. Gonzalez

Mutual co-authors in cluster

Author profile →

8 papers

Recent·Most cited

Proteomics and phosphoproteomics profiling of the co-formulation of type I and II interferons, HeberFERON, in the glioblastoma-derived cell line U-87 MG

D. Vazquez-Blomquist, A. Hardy-Sosa, S. C. Baez, V. Besada, S. Palomares, O. Guirola, Y. Ramos, J. R. Wisniewski, L. J. Gonzalez, I. Bello-Rivero

This study uses proteomic and phosphoproteomic analyses to investigate the effects of HeberFERON on U-87 MG glioblastoma cells, identifying key pathways and phosphosites involved in antiproliferative responses.

bioRxiv · Oct 3, 2022 · PreprintCancer Biology

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection

A. C. Ramon, G. V. Perez, E. Caballero, M. Rosales, D. Aguilar, D. M. Vazquez-Blomquist, Y. Ramos, A. Rodriguez, V. Falcon, M. P. Rodriguez, Y. Ke, Y. Perera, S. E. Perea

This study shows that CIGB-325, an anti-CK2 peptide, inhibits bovine coronavirus infection by reducing viral protein accumulation and cytopathic effects.

bioRxiv · Jun 8, 2021Pharmacology & Toxicology

Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300

M. Rosales, G. V. Perez, A. C. Ramon, Y. Cruz, A. Rodriguez-Ulloa, V. Besada, Y. Ramos, D. Vazquez-Blomquist, E. Caballero, D. Aguilar, L. J. Gonzalez, K. Zettl, J. R. Wisniewski, Y. Ke, Y. Perera, S. E. Perea

This study investigates the anti-proliferative and proapoptotic effects of the CK2 inhibitor CIGB-300 on AML cells and identifies its molecular targets.

bioRxiv · May 19, 2021Cancer Biology

In-solution buffer-free digestion for the analysis of SARS-CoV-2 RBD proteins allows a full sequence coverage and detection of post-translational modifications in a single ESI-MS spectrum

L. A. Espinosa, Y. Ramos, I. Andujar, E. O. Torres, G. Cabrera, A. Martin, D. Gonzalez, G. Chinea, M. Becquet, I. Gonzalez, C. Canaan-Haden, E. Nelson, G. Rojas, B. Perez-Masson, D. Perez-Martinez, , L. J. Gonzalez

This paper introduces an in-solution buffer-free digestion method for analyzing SARS-CoV-2 RBD proteins, achieving full sequence coverage and detecting post-translational modifications in a single ESI-MS spectrum.

bioRxiv · May 10, 2021 · PreprintBiochemistry

Gel Electrophoresis/Electroelution Sorting Fractionator combined with Filter Aided Sample preparation (FASP) for deep proteomic analysis.

Y. Ramos, A. Almeida, J. Carpio, A. Rodriguez-Ulloa, Y. Perera, L. J. Gonzalez, J. R. Wisniewski, V. Besada

The paper introduces a new device for protein fractionation and demonstrates its effectiveness in increasing protein identification in proteomic analysis.

bioRxiv · Apr 16, 2021Bioengineering

SARS-CoV-2 RBD-Tetanus toxoid conjugate vaccine induces a strong neutralizing immunity in preclinical studies

Y. Valdes-Balbin, D. Santana-Mederos, L. Quintero, S. Fernandez, L. Rodriguez, B. Sanchez-Ramirez, R. Perez, C. Acosta, Y. Mendez, M. G. Ricardo, T. Hernandez, G. Bergado, F. Pi, A. Valdes, T. Carmenate, , Garcia-Rivera

bioRxiv · Feb 8, 2021Immunology

Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945

M. Rosales, A. Rodriguez-Ulloa, V. Besada, A. C. Ramon, G. V. Perez, Y. Ramos, O. Guirola, L. J. Gonzalez, K. Zettl, J. R. Wisniewski, Y. Perera, S. E. Perea

This study examines the phosphoproteomic changes in AML cell lines treated with CX-4945, identifying key biological processes and pathways affected by CK2 inhibition.

bioRxiv · Jan 4, 2021Cancer Biology

The low-density lipoprotein receptor-related protein-1 is essential for Dengue virus infection

V. Huerta Galindo, A. M. Martin, M. Sarria, O. Guirola, A. Yero, Y. Ramos, D. Pupo, D. Martin, A. Marcello, G. Chinea

This paper identifies LRP1 as a new receptor for Dengue virus entry, showing it binds the viral envelope protein and inhibits infection, suggesting it as a potential drug target.

bioRxiv · Jun 10, 2020Biochemistry